Cargando…
Influenza Virus Drug Resistance: A Time-Sampled Population Genetics Perspective
The challenge of distinguishing genetic drift from selection remains a central focus of population genetics. Time-sampled data may provide a powerful tool for distinguishing these processes, and we here propose approximate Bayesian, maximum likelihood, and analytical methods for the inference of dem...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3937227/ https://www.ncbi.nlm.nih.gov/pubmed/24586206 http://dx.doi.org/10.1371/journal.pgen.1004185 |
_version_ | 1782305455037480960 |
---|---|
author | Foll, Matthieu Poh, Yu-Ping Renzette, Nicholas Ferrer-Admetlla, Anna Bank, Claudia Shim, Hyunjin Malaspinas, Anna-Sapfo Ewing, Gregory Liu, Ping Wegmann, Daniel Caffrey, Daniel R. Zeldovich, Konstantin B. Bolon, Daniel N. Wang, Jennifer P. Kowalik, Timothy F. Schiffer, Celia A. Finberg, Robert W. Jensen, Jeffrey D. |
author_facet | Foll, Matthieu Poh, Yu-Ping Renzette, Nicholas Ferrer-Admetlla, Anna Bank, Claudia Shim, Hyunjin Malaspinas, Anna-Sapfo Ewing, Gregory Liu, Ping Wegmann, Daniel Caffrey, Daniel R. Zeldovich, Konstantin B. Bolon, Daniel N. Wang, Jennifer P. Kowalik, Timothy F. Schiffer, Celia A. Finberg, Robert W. Jensen, Jeffrey D. |
author_sort | Foll, Matthieu |
collection | PubMed |
description | The challenge of distinguishing genetic drift from selection remains a central focus of population genetics. Time-sampled data may provide a powerful tool for distinguishing these processes, and we here propose approximate Bayesian, maximum likelihood, and analytical methods for the inference of demography and selection from time course data. Utilizing these novel statistical and computational tools, we evaluate whole-genome datasets of an influenza A H1N1 strain in the presence and absence of oseltamivir (an inhibitor of neuraminidase) collected at thirteen time points. Results reveal a striking consistency amongst the three estimation procedures developed, showing strongly increased selection pressure in the presence of drug treatment. Importantly, these approaches re-identify the known oseltamivir resistance site, successfully validating the approaches used. Enticingly, a number of previously unknown variants have also been identified as being positively selected. Results are interpreted in the light of Fisher's Geometric Model, allowing for a quantification of the increased distance to optimum exerted by the presence of drug, and theoretical predictions regarding the distribution of beneficial fitness effects of contending mutations are empirically tested. Further, given the fit to expectations of the Geometric Model, results suggest the ability to predict certain aspects of viral evolution in response to changing host environments and novel selective pressures. |
format | Online Article Text |
id | pubmed-3937227 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-39372272014-03-04 Influenza Virus Drug Resistance: A Time-Sampled Population Genetics Perspective Foll, Matthieu Poh, Yu-Ping Renzette, Nicholas Ferrer-Admetlla, Anna Bank, Claudia Shim, Hyunjin Malaspinas, Anna-Sapfo Ewing, Gregory Liu, Ping Wegmann, Daniel Caffrey, Daniel R. Zeldovich, Konstantin B. Bolon, Daniel N. Wang, Jennifer P. Kowalik, Timothy F. Schiffer, Celia A. Finberg, Robert W. Jensen, Jeffrey D. PLoS Genet Research Article The challenge of distinguishing genetic drift from selection remains a central focus of population genetics. Time-sampled data may provide a powerful tool for distinguishing these processes, and we here propose approximate Bayesian, maximum likelihood, and analytical methods for the inference of demography and selection from time course data. Utilizing these novel statistical and computational tools, we evaluate whole-genome datasets of an influenza A H1N1 strain in the presence and absence of oseltamivir (an inhibitor of neuraminidase) collected at thirteen time points. Results reveal a striking consistency amongst the three estimation procedures developed, showing strongly increased selection pressure in the presence of drug treatment. Importantly, these approaches re-identify the known oseltamivir resistance site, successfully validating the approaches used. Enticingly, a number of previously unknown variants have also been identified as being positively selected. Results are interpreted in the light of Fisher's Geometric Model, allowing for a quantification of the increased distance to optimum exerted by the presence of drug, and theoretical predictions regarding the distribution of beneficial fitness effects of contending mutations are empirically tested. Further, given the fit to expectations of the Geometric Model, results suggest the ability to predict certain aspects of viral evolution in response to changing host environments and novel selective pressures. Public Library of Science 2014-02-27 /pmc/articles/PMC3937227/ /pubmed/24586206 http://dx.doi.org/10.1371/journal.pgen.1004185 Text en © 2014 Foll et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Foll, Matthieu Poh, Yu-Ping Renzette, Nicholas Ferrer-Admetlla, Anna Bank, Claudia Shim, Hyunjin Malaspinas, Anna-Sapfo Ewing, Gregory Liu, Ping Wegmann, Daniel Caffrey, Daniel R. Zeldovich, Konstantin B. Bolon, Daniel N. Wang, Jennifer P. Kowalik, Timothy F. Schiffer, Celia A. Finberg, Robert W. Jensen, Jeffrey D. Influenza Virus Drug Resistance: A Time-Sampled Population Genetics Perspective |
title | Influenza Virus Drug Resistance: A Time-Sampled Population Genetics Perspective |
title_full | Influenza Virus Drug Resistance: A Time-Sampled Population Genetics Perspective |
title_fullStr | Influenza Virus Drug Resistance: A Time-Sampled Population Genetics Perspective |
title_full_unstemmed | Influenza Virus Drug Resistance: A Time-Sampled Population Genetics Perspective |
title_short | Influenza Virus Drug Resistance: A Time-Sampled Population Genetics Perspective |
title_sort | influenza virus drug resistance: a time-sampled population genetics perspective |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3937227/ https://www.ncbi.nlm.nih.gov/pubmed/24586206 http://dx.doi.org/10.1371/journal.pgen.1004185 |
work_keys_str_mv | AT follmatthieu influenzavirusdrugresistanceatimesampledpopulationgeneticsperspective AT pohyuping influenzavirusdrugresistanceatimesampledpopulationgeneticsperspective AT renzettenicholas influenzavirusdrugresistanceatimesampledpopulationgeneticsperspective AT ferreradmetllaanna influenzavirusdrugresistanceatimesampledpopulationgeneticsperspective AT bankclaudia influenzavirusdrugresistanceatimesampledpopulationgeneticsperspective AT shimhyunjin influenzavirusdrugresistanceatimesampledpopulationgeneticsperspective AT malaspinasannasapfo influenzavirusdrugresistanceatimesampledpopulationgeneticsperspective AT ewinggregory influenzavirusdrugresistanceatimesampledpopulationgeneticsperspective AT liuping influenzavirusdrugresistanceatimesampledpopulationgeneticsperspective AT wegmanndaniel influenzavirusdrugresistanceatimesampledpopulationgeneticsperspective AT caffreydanielr influenzavirusdrugresistanceatimesampledpopulationgeneticsperspective AT zeldovichkonstantinb influenzavirusdrugresistanceatimesampledpopulationgeneticsperspective AT bolondanieln influenzavirusdrugresistanceatimesampledpopulationgeneticsperspective AT wangjenniferp influenzavirusdrugresistanceatimesampledpopulationgeneticsperspective AT kowaliktimothyf influenzavirusdrugresistanceatimesampledpopulationgeneticsperspective AT schifferceliaa influenzavirusdrugresistanceatimesampledpopulationgeneticsperspective AT finbergrobertw influenzavirusdrugresistanceatimesampledpopulationgeneticsperspective AT jensenjeffreyd influenzavirusdrugresistanceatimesampledpopulationgeneticsperspective |